COPD: what is the unmet need?
Chronic obstructive pulmonary disease (COPD) is now recognized as a major source of ill health around the world with an important impact on both developed and developing economies. The emphasis in research has shifted from a purely physiological focus that mainly considered how airway smooth muscle tone can be modulated to improve lung emptying. Although long-acting inhaled beta-agonist and antimuscarinic antagonists have improved clinical management for many symptomatic patents, there is increasing attention being paid to the inflammatory component of COPD in the airways and lung parenchyma and to its close association with other diseases, which cannot simply be attributed to their having a common risk factor such as tobacco smoking. This clinical review is intended to identify not only those areas where pharmacological treatment has been successful or has offered particular insights into COPD but also to consider where existing treatment is falling short and new opportunities exist to conduct original investigations. A picture of considerable complexity emerges with a range of clinical patterns leading to several common end points such as exacerbations, exercise impairment and mortality. Defining subsets of patients responsive to more specific interventions is the major challenge for the next decade in this field.
Calverley
P M A
PM
School of Clinical Sciences, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. pmacal@liverpool.ac.uk
D018450:Disease Progression; D015444:Exercise; D006301:Health Services Needs and Demand; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D018579:Patient Selection; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
Chest. 2007 Mar;131(3):682-689
17356080
Thorax. 2007 Feb;62(2):115-20
17090575
Thorax. 2006 May;61(5):440-7
16648352
Eur Respir J. 2006 Jan;27(1):188-207
16387952
Am J Respir Crit Care Med. 2000 May;161(5):1608-13
10806163
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1517-22
16166613
JAMA. 1994 Nov 16;272(19):1497-505
7966841
Am J Respir Crit Care Med. 2006 Apr 15;173(8):842-6
16439716
Lancet. 2004 Aug 21-27;364(9435):709-21
15325838
Thorax. 2008 Aug;63(8):683-9
18487318
Lancet. 2007 Sep 1;370(9589):751-7
17765524
Chest. 2003 Jul;124(1):83-9
12853506
Eur Respir J. 2008 Feb;31(2):416-69
18238951
Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43
16424444
Thorax. 2005 Nov;60(11):916-24
15994253
Ann Intern Med. 1980 Sep;93(3):391-8
6776858
Lancet. 2007 Sep 1;370(9589):741-50
17765523
N Engl J Med. 2003 May 22;348(21):2059-73
12759479
Thorax. 2006 Mar;61(3):189-95
16227328
Lancet. 2001 May 19;357(9268):1571-5
11377644
Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26
17916806
BMJ. 2006 Jun 3;332(7553):1324-6
16740563
Am J Respir Crit Care Med. 2007 Aug 1;176(3):285-90
17478615
Am J Respir Crit Care Med. 2004 Dec 15;170(12):1286-93
15374843
N Engl J Med. 2003 May 22;348(21):2092-102
12759480
Chest. 2002 Apr;121(4):1042-50
11948031
Ann Intern Med. 1999 Mar 2;130(5):397-403
10068413
BMJ. 2005 Nov 5;331(7524):1050
16234255
Ann Intern Med. 2005 Feb 15;142(4):233-9
15710956
Thorax. 2003 Nov;58(11):937-41
14586043
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
17507545
Lancet. 1981 Mar 28;1(8222):681-6
6110912
Eur Respir J. 2005 Oct;26(4):623-9
16204592
Lancet. 2005 Apr 30-May 6;365(9470):1552-60
15866309
Chest. 2006 Jul;130(1):133-42
16840393
Am J Med. 2002 Jul;113(1):59-65
12106623
Proc Am Thorac Soc. 2006 Apr;3(2):180-4
16565429
N Engl J Med. 2007 Feb 22;356(8):775-89
17314337
Am J Respir Crit Care Med. 2006 Apr 15;173(8):865-70
16439720
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1468-72
10556107
Lancet. 1999 May 29;353(9167):1819-23
10359405
Thorax. 2006 Jul;61(7):559-67
16467067
Thorax. 2005 Jul;60(7):531-7
15994258
Eur Respir J. 2007 Sep;30(3):467-71
17504799
BMJ. 1994 Oct 8;309(6959):901-11
7755693
J Am Coll Cardiol. 2006 Jun 20;47(12):2554-60
16781387
N Engl J Med. 2004 Jun 24;350(26):2645-53
15215480
BMJ. 2003 Jan 25;326(7382):185
12543832
N Engl J Med. 2005 May 12;352(19):1967-76
15888697
Thorax. 2005 Nov;60(11):925-31
16055622
Eur Respir J. 2006 Dec;28(6):1245-57
17138679
Lancet. 2007 Sep 1;370(9589):774-85
17765527
BMJ. 2000 May 13;320(7245):1297-303
10807619
Eur Respir J. 2004 Jul;24(1):86-94
15293609
Eur Respir J. 2004 May;23(5):698-702
15176682
Am J Respir Crit Care Med. 2001 Mar;163(4):892-8
11282762
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22
9603117
Am J Respir Crit Care Med. 2001 Jan;163(1):122-8
11208636
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):701-6
8810608
Respir Med. 2007 Apr;101(4):746-53
17000096
Eur Respir J. 2004 Mar;23(3):391-5
15065827
Eur Respir J. 2004 Jun;23(6):832-40
15218994
Am J Respir Crit Care Med. 2003 Mar 15;167(6):880-8
12505859
Thorax. 2003 Sep;58(9):745-51
12947128
JAMA. 2006 Jul 5;296(1):47-55
16820546
Am J Respir Crit Care Med. 2007 Jun 15;175(12):1259-65
17363772
Am J Med. 2003 Jan;114(1):10-4
12543283
Eur Respir J. 2002 Oct;20(4):799-805
12412667
Ann Intern Med. 2007 Apr 17;146(8):545-55
17310045
Eur Respir J. 2002 Oct;20(4):819-25
12412670